Cannara Biotech Inc LOVE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LOVE is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- CAD 0.83
- Day Range
- CAD 0.83–0.85
- 52-Week Range
- CAD 0.75–1.15
- Bid/Ask
- CAD 0.84 / CAD 0.88
- Market Cap
- CAD 75.62 Mil
- Volume/Avg
- 35,246 / 22,119
Key Statistics
- Price/Earnings (Normalized)
- 8.09
- Price/Sales
- 1.12
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- 0.50%
Company Profile
Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- —
- Website
- http://www.cannara.ca
Comparables
Valuation
|
Metric
|
LOVE
|
CRON
|
CURA
|
|---|---|---|---|
Price/Earnings (Normalized) | 8.09 | — | — |
Price/Book Value | 0.91 | 0.89 | 3.61 |
Price/Sales | 1.12 | 11.03 | 2.73 |
Price/Cash Flow | 7.42 | — | 64.41 |
Price/Earnings
LOVE
CRON
CURA
Financial Strength
|
Metric
|
LOVE
|
CRON
|
CURA
|
|---|---|---|---|
Quick Ratio | 0.56 | 21.68 | 0.31 |
Current Ratio | 2.37 | 22.54 | 0.85 |
Interest Coverage | 3.51 | — | −0.24 |
Quick Ratio
LOVE
CRON
CURA
Profitability
|
Metric
|
LOVE
|
CRON
|
CURA
|
|---|---|---|---|
Return on Assets (Normalized) | 7.53% | −0.53% | −3.72% |
Return on Equity (Normalized) | 13.55% | −0.55% | −10.45% |
Return on Invested Capital (Normalized) | 10.41% | −4.90% | −2.20% |
Return on Assets
LOVE
CRON
CURA
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
MKKGY
| Merck KGaA ADR | Fqvxpnfdx | Tsshzv | $70.9 Bil | |
ZTS
| Zoetis Inc Class A | Jrksxqqfgv | Wkgh | $68.9 Bil | |
HLN
| Haleon PLC ADR | Wpvfcxdk | Pvnf | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Gttczvr | Xbzmv | $14.7 Bil | |
VTRS
| Viatris Inc | Zqrltxvk | Wld | $13.7 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Xgvrdts | Hhf | $11.9 Bil | |
CTLT
| Catalent Inc | Bgxpqwcz | Zppmp | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Xwlkqdqbj | Wvsd | $4.1 Bil | |
CURLF
| Curaleaf Holdings Inc | Ndfjqvzh | Kpdgc | $3.6 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Scvmhtxqh | Zjzrks | $3.5 Bil |